Pancreatic Cancer Research

ResearcherVeterans Health AdministrationActive in the last 2 years

Adetunji T. Toriola

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1079-2606; OpenAlex author ID A5090275616. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 8

  1. Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-16245-1↗
  2. Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus. Co-author DOI 10.1158/1055-9965.epi-19-0781↗
  3. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis. Co-author DOI 10.1097/mpa.0000000000000989↗
  4. No Association Between Nonsteroidal Anti-inflammatory Drug Use and Pancreatic Cancer Incidence and Survival. Last author DOI 10.1097/mpa.0000000000000809↗
  5. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival. Co-author DOI 10.1245/s10434-017-5988-y↗
  6. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancrea… Co-author DOI 10.1016/s1470-2045(16)00078-4↗
  7. Diabetes and pancreatic cancer survival: a prospective cohort-based study. Co-author DOI 10.1038/bjc.2014.224↗
  8. Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected]. Co-author DOI 10.2217/fon.14.88↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ryan C Fields · 3 shared papers, 2014–2024 · strength 0.32
  2. Rachael Z. Stolzenberg‐Solomon · 4 shared papers, 2014–2018 · strength 0.30
  3. William G. Hawkins · 2 shared papers, 2016–2024 · strength 0.23
  4. Timothy M. Nywening · 2 shared papers, 2016–2024 · strength 0.23
  5. Joshua D. Mitchell · 1 shared paper, 2024 · strength 0.19
  6. Linda R. Peterson · 1 shared paper, 2024 · strength 0.19
  7. Usman Younis Panni · 1 shared paper, 2024 · strength 0.19
  8. Joseph E. Ippolito · 1 shared paper, 2024 · strength 0.19
  9. Kenneth Robert Carson · 1 shared paper, 2020 · strength 0.13
  10. Kristen Marie Sanfilippo · 1 shared paper, 2020 · strength 0.13
  11. David C. Linehan · 2 shared papers, 2014–2016 · strength 0.10
  12. Michaël Pollak · 1 shared paper, 2017 · strength 0.09
  13. A. Lad · 1 shared paper, 2017 · strength 0.08
  14. Sara H. Olson · 1 shared paper, 2018 · strength 0.08
  15. Rayjean J. Hung RJ · 1 shared paper, 2018 · strength 0.08
  16. Sean Patrick Cleary · 1 shared paper, 2018 · strength 0.08
  17. Cristina Bosetti · 1 shared paper, 2018 · strength 0.08
  18. Robert C. Kurtz · 1 shared paper, 2018 · strength 0.08
  19. Christie Y. Jeon · 1 shared paper, 2018 · strength 0.08
  20. Miquel S. Porta · 1 shared paper, 2018 · strength 0.08
  21. Donghui Li · 1 shared paper, 2018 · strength 0.08
  22. Carlo La Vecchia · 1 shared paper, 2018 · strength 0.08
  23. Graham A. Colditz · 1 shared paper, 2014 · strength 0.06
  24. Kathryn Jane Fowler · 1 shared paper, 2016 · strength 0.04
  25. Dominic E. Sanford · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.